stock
gist
Home
Top Movers
Companies
Concepts
Filings
Toggle search
SCHEDULE 13G/A - Silence Therapeutics plc | StockGist | StockGist
Companies
SLNCF
SCHEDULE 13G/A
stock
gist
Home
Top Movers
Companies
Concepts
Filings
Toggle search
Home
Filings
SLNCF
SCHEDULE 13G/A
SCHEDULE 13G/A
Beneficial Ownership
Amendment
Silence Therapeutics plc
Filed Feb 9, 2026
Accepted Feb 9, 2026, 12:00 AM ET
SLNCF
CIK 0001479615
View on SEC.gov
Company Profile
0000908834-26-000072
Beneficial Ownership Report
Passive Investment
Shares Owned
5,935,955
Reporting Person
Silence Therapeutics plc
Person Type
IA